Quantitative Proteomic Profiling of Prostate Cancer Reveals a Role for miR-128 in Prostate Cancer
Open Access
- 1 February 2010
- journal article
- Published by Elsevier BV in Molecular & Cellular Proteomics
- Vol. 9 (2), 298-312
- https://doi.org/10.1074/mcp.m900159-mcp200
Abstract
No abstract availableKeywords
This publication has 84 references indexed in Scilit:
- Mortality Results from a Randomized Prostate-Cancer Screening TrialThe New England Journal of Medicine, 2009
- Screening and Prostate-Cancer Mortality in a Randomized European StudyThe New England Journal of Medicine, 2009
- Metabolomic profiles delineate potential role for sarcosine in prostate cancer progressionNature, 2009
- Androgen receptor is a tumor suppressor and proliferator in prostate cancerProceedings of the National Academy of Sciences of the United States of America, 2008
- Analysis and validation of proteomic data generated by tandem mass spectrometryNature Methods, 2007
- Poor prognosis in carcinoma is associated with a gene expression signature of aberrant PTEN tumor suppressor pathway activityProceedings of the National Academy of Sciences of the United States of America, 2007
- Silencing of microRNAs in vivo with ‘antagomirs’Nature, 2005
- Gene expression analysis of prostate cancersMolecular Carcinogenesis, 2002
- Delineation of prognostic biomarkers in prostate cancerNature, 2001
- Distinct types of diffuse large B-cell lymphoma identified by gene expression profilingNature, 2000